BDBM339924 3-(Morpholin-4-yl)propyl 5-{[(3S)-1-[(trans-4-{(1S)-1-[(tert-butoxycarbonyl)amino]-2-fluoroethyl}cyclohexyl)carbonyl]-3-(trans-4-methoxycyclohexyl)-L-prolyl]amino}-1-benzofuran-2-carboxylate::US9758480, 201

SMILES COC1CCC([C@@H]2CCN(C(=O)[C@H]3CC[C@H]([C@H](N)CF)CC3)[C@@H]2C(=O)Nc2ccc3oc(C(=O)OCC(C)C)cc3c2)CC1

InChI Key InChIKey=VRSZNBPXJIQYDM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 339924   

TargetCoagulation factor XI(Human)
Sumitomo Dainippon Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 339924BDBM339924(US9758480, 201 | 3-(Morpholin-4-yl)propyl 5-{[(3S)...)
Affinity DataIC50: 4.10E+3nMAssay Description:0.35 μg/mL human FXIa was allowed to react with a substrate and a test compound in a 30 mmol/L HEPES buffer solution (pH 7.4) that contained 145...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/22/2019
Entry Details
US Patent